For many women, the conversation around cardiovascular risk is often framed as a concern for the later chapters of life. However, emerging data suggests that the window of vulnerability opens much earlier than previously thought, specifically during the transitional phase leading up to menopause.
A scientific analysis from the American Heart Association (AHA) indicates that women experiencing perimenopause—the period marked by erratic menstrual cycles and fluctuating hormones—often see a measurable decline in their cardiovascular health. According to the research, these women are likely to have lower heart-health scores than those who are still experiencing regular periods, suggesting that perimenopause heart health challenges begin well before the official onset of menopause.
Perimenopause typically begins in a woman’s thirties or forties and can last anywhere from four to eight years. It concludes only when a woman enters menopause, which is clinically defined as the point one year after her last menstrual cycle. For clinicians and patients alike, this transition is increasingly viewed not just as a reproductive milestone, but as a critical cardiovascular turning point.
“We as a medical community are increasingly realizing the impact of reproductive health on cardiovascular disease over the lifespan,” says Ersilia M. DeFilippis, MD, a cardiologist specializing in advanced heart failure and transplants at NewYork-Presbyterian Columbia University Irving Medical Center in New York City.
The Data: A Decline in Cardiovascular Scores
The AHA analysis utilized data from the National Health and Nutrition Examination Survey (NHANES), tracking more than 9,000 women between the ages of 18 and 80 from 2007 to 2020. To quantify heart health, researchers used “Life’s Essential 8,” a comprehensive framework developed by the American Heart Association that measures diet, sleep, exercise, and other key biometric markers.
The findings reveal a stark contrast in health trajectories. Perimenopausal women were twice as likely to have an overall low heart-health score—defined as a score below 50—compared to premenopausal women. While scores declined further in postmenopausal women, the drop during the perimenopausal transition was significant enough to alarm experts.
Beyond the general score, the analysis highlighted specific metabolic struggles. Perimenopausal women were 76 percent more likely to struggle with higher cholesterol and elevated blood sugar than their younger peers. The researchers noted a consistent decline in diet quality as women aged, with nutrition consistently receiving the lowest scores across all reproductive stages.
| Reproductive Stage | Heart Health Trend | Key Risk Factors |
|---|---|---|
| Premenopausal | Baseline / Higher Scores | General lifestyle factors |
| Perimenopausal | Significant Decline | $uparrow$ Cholesterol, $uparrow$ Blood Sugar |
| Postmenopausal | Lowest Scores | Chronic cardiovascular risk |
How Hormonal Shifts Drive Heart Risk
The primary driver of these changes is the fluctuation and eventual decline of estrogen. Estrogen plays a protective role in the cardiovascular system, and its loss triggers a cascade of physiological shifts. Dr. DeFilippis explains that as estrogen levels fall, LDL (the “bad” cholesterol) tends to increase, and insulin resistance can worsen.
Insulin resistance occurs when the body’s cells do not respond effectively to insulin, which can lead to increased blood sugar levels and a higher risk of developing type 2 diabetes. Lower estrogen levels can cause blood vessels to become stiffer, which directly contributes to an increase in blood pressure.
Weight gain also becomes a more prominent challenge during this transition, serving as another risk factor for heart disease. Lauren Streicher, MD, a clinical professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine in Chicago, notes that the body receives “mixed messages” from the surges and dips of estrogen during perimenopause, often responding in ways that are not health-optimizing.
The timing of this loss is critical. Women who experience premature menopause at age 40 or early menopause at 45 face a higher long-term risk of heart disease because they lose the protective effects of estrogen earlier in their lives.
A Critical Window for Preventative Action
Despite the concerning data, experts emphasize that perimenopause represents a prime opportunity for intervention. Because these changes occur over several years, women have a window to implement lifestyle changes before those changes evolve into a formal diagnosis.
“Perimenopause is the time to look at cardiovascular health and make changes — not five years later,” says Dr. Streicher.
Cardiologists recommend a multi-pronged approach to combat these risks:
- Nutritional Shifts: Prioritizing a diet rich in vegetables, fruits, whole grains, lean proteins, and minimally processed foods.
- Physical Activity: Engaging in regular exercise to combat insulin resistance and manage weight.
- Medical Surveillance: Moving beyond hormone testing to prioritize blood pressure and cholesterol screenings.
- Hormone Therapy: Discussing hormone replacement therapy (HRT) with a provider, which Dr. Streicher notes can improve quality of life and potentially impact long-term cardiovascular risk.
Catherine Weinberg, MD, a cardiologist at Northwell Lenox Hill Hospital in New York City, describes the decline in diet quality across all stages as “concerning,” noting that nutrition is where the largest gains in heart health are still available.
Understanding the Study’s Limitations
While the analysis provides a vital signal, it is important to note certain constraints in the data. The study relied on self-reported information regarding menstrual history and lifestyle factors, such as smoking and activity levels, which can introduce inaccuracies.
the researchers lacked comprehensive data on all participants regarding the use of hormone replacement therapy or whether a woman had undergone an oophorectomy (removal of the ovaries), both of which significantly influence cardiovascular health. Most notably, the perimenopausal group was relatively small—consisting of only 205 women out of the 9,000 participants—which may limit the representativeness of the findings for all women in this life stage.
Regardless of these limitations, the consensus among the specialists is clear: the transition to menopause is a time of vulnerability that requires proactive medical engagement.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
As the medical community continues to integrate reproductive health into cardiovascular care, the next step for many women will be advocating for comprehensive heart screenings during their annual gynecological exams. The goal is to shift the clinical focus from merely managing symptoms like hot flashes to actively preventing heart disease.
Do you think heart health is discussed enough during the transition to menopause? Share your thoughts in the comments or share this article with someone who may find it helpful.
